Inogen (INGN) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.97% |
| Dec 31, 2025 | -2.84% |
| Sep 30, 2025 | -2.97% |
| Jun 30, 2025 | 12.42% |
| Mar 31, 2025 | -5.06% |
| Dec 31, 2024 | -5.10% |
| Sep 30, 2024 | -1.19% |
| Jun 30, 2024 | 0.39% |
| Mar 31, 2024 | -7.59% |
| Dec 31, 2023 | -18.65% |
| Sep 30, 2023 | -11.17% |
| Jun 30, 2023 | 0.48% |
| Mar 31, 2023 | 0.36% |
| Dec 31, 2022 | 0.58% |
| Sep 30, 2022 | 6.77% |
| Jun 30, 2022 | 6.39% |
| Mar 31, 2022 | 7.10% |
| Dec 31, 2021 | 4.86% |
| Sep 30, 2021 | 7.41% |
| Jun 30, 2021 | 8.48% |
| Mar 31, 2021 | 14.21% |
| Dec 31, 2020 | 10.03% |
| Sep 30, 2020 | 15.07% |
| Jun 30, 2020 | 9.56% |
| Mar 31, 2020 | 39.98% |
| Dec 31, 2019 | 46.31% |
| Sep 30, 2019 | 27.91% |
| Jun 30, 2019 | 27.16% |
| Mar 31, 2019 | 93.85% |
| Dec 31, 2018 | 70.94% |
| Sep 30, 2018 | 118.21% |
| Jun 30, 2018 | 159.64% |
| Mar 31, 2018 | 169.01% |